Surrogate endpoints in breast cancer screening trials

Lancet Oncol. 2022 Aug;23(8):e360. doi: 10.1016/S1470-2045(22)00370-9.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biomarkers
  • Breast Neoplasms* / diagnosis
  • Breast Neoplasms* / prevention & control
  • Early Detection of Cancer
  • Endpoint Determination
  • Female
  • Humans

Substances

  • Biomarkers